Company News

Gan & Lee Pharmaceuticals announces the issuance of US patent on its molecular chaperone technology

  • Time: 2005-08-02 19:30:00
  • Click Rate: 12005

Beijing, China - August 2, 2005 - Gan & Lee Pharmaceuticals (Gan & Lee) received issue notification from the United States Patent and Trademark Office that the Company's patent on its molecular chaperone techology for insulin production has been issued. The issuance of this patent represents a milestone in recognition of the company's core advanced techonogy.

Gan & Lee has sophisticated manufacturing proceses, including high-density fermentation and protein purification technologies as well as a sound quality control system. The molecular chaperone technology significantly simplifies the manufacturing process and reduces production cost. The issuance of this patent further strengthens the company's leading position in the manufacturing of recombinant human insulin and insulin analogs.